240
Participants
Start Date
March 11, 2019
Primary Completion Date
November 30, 2026
Study Completion Date
April 30, 2027
Tuspetinib
Daily (QD), continuous dosing
Venetoclax Oral Tablet
Venetoclax will be given to study participants in the Part C tuspetinib plus venetoclax combination treatment group either in 50 mg or 100 mg tablets
Azacitidine for Intravenous Infusion
Azacitidine will be given to study participants in Part D as intravenous infusion at a dose of 75 mg/m\^2
ACTIVE_NOT_RECRUITING
Auckland City Hospital, Grafton
ACTIVE_NOT_RECRUITING
Border Medical Oncology, Albury
ACTIVE_NOT_RECRUITING
St Vincent's Hospital Melbourne, Fitzroy
ACTIVE_NOT_RECRUITING
Royal Brisbane and Women's Hospital, Herston
ACTIVE_NOT_RECRUITING
Townsville University Hospital, Townsville
ACTIVE_NOT_RECRUITING
Sir Charles Gairdner Hospital, Nedlands
ACTIVE_NOT_RECRUITING
Charité Universitätsmedizin Berlin, Berlin
ACTIVE_NOT_RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Duke University Medical Center, Durham
ACTIVE_NOT_RECRUITING
Hospital Quirón Madrid, Pozuelo de Alarcón
ACTIVE_NOT_RECRUITING
Emory University, Atlanta
ACTIVE_NOT_RECRUITING
Hospital Universitario Central de Asturias, Oviedo
RECRUITING
University of Miami - Miller School of Medicine, Miami
RECRUITING
The Kirklin Clinic of UAB Hospital, Birmingham
ACTIVE_NOT_RECRUITING
Kyungpook National University Hospital, Daegu
RECRUITING
The Ohio State University Wexner Medical Center, Columbus
ACTIVE_NOT_RECRUITING
Cleveland Clinic - Taussig Cancer Center, Cleveland
ACTIVE_NOT_RECRUITING
Hospital Clinico Universitario de Valencia, Valencia
ACTIVE_NOT_RECRUITING
Hospital Universitari i Politècnic La Fe, Valencia
ACTIVE_NOT_RECRUITING
Pusan National University Hospital, Pusan
RECRUITING
MD Anderson Cancer Center, Huston
RECRUITING
USC/Norris Comprehensive Cancer Center, Los Angeles
ACTIVE_NOT_RECRUITING
City of Hope Comprehensive Cancer Center, Duarte
ACTIVE_NOT_RECRUITING
UCSD Moores Cancer Center, La Jolla
RECRUITING
University of California Irvine, Irvine
RECRUITING
Stanford Cancer Center, Palo Alto
RECRUITING
University of California, Davis, Sacramento
RECRUITING
Yale University, New Haven
ACTIVE_NOT_RECRUITING
Massachusetts General Hospital, Boston
ACTIVE_NOT_RECRUITING
Universitätsklinikum Leipzig, Leipzig
COMPLETED
Seoul National University Hospital, Seoul
ACTIVE_NOT_RECRUITING
Asan Medical Center, Seoul
ACTIVE_NOT_RECRUITING
Samsung Medical Center, Seoul
ACTIVE_NOT_RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
Lead Sponsor
Aptose Biosciences Inc.
INDUSTRY